Jörg König Selected Research

Jörg König Research Topics

Disease

4	Neoplasms (Cancer) 01/2015 - 06/2005
3	Insulin Resistance 07/2021 - 08/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2014 - 06/2008
3	Type 2 Diabetes Mellitus (MODY) 04/2013 - 06/2008
3	Drug-Related Side Effects and Adverse Reactions 10/2011 - 02/2010
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2017
2	Obesity 01/2020 - 01/2017
2	Breast Neoplasms (Breast Cancer) 07/2013 - 03/2011
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 08/2012 - 11/2003
1	Brain Diseases (Brain Disorder) 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Epilepsy (Aura) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	COVID-19 03/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Fatty Liver 01/2020
1	Melanoma (Melanoma, Malignant) 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2015
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015
1	Multiple Myeloma 01/2015
1	Carcinoma (Carcinomatosis) 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Sclerosing Cholangitis 08/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2011
1	Glaucoma 05/2010
1	Body Weight (Weight, Body) 02/2010
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2006
1	Glioma (Gliomas) 12/2005
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2005
1	Liver Diseases (Liver Disease) 11/2003
1	Hepatocellular Carcinoma (Hepatoma) 04/2003

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2022 - 06/2005
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2005
3	citrate-binding transport proteinIBA 01/2022 - 01/2017
3	Organic Anion TransportersIBA 07/2013 - 04/2003
3	Hypoglycemic Agents (Hypoglycemics)IBA 04/2013 - 06/2008
2	SodiumIBA 01/2022 - 01/2020
2	LipidsIBA 07/2021 - 01/2021
2	CationsIBA 01/2015 - 06/2008
2	Peptides (Polypeptides)IBA 07/2013 - 06/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2011 - 06/2008
2	Messenger RNA (mRNA)IBA 03/2011 - 06/2005
2	AnionsIBA 06/2008 - 12/2005
2	Adenosine Triphosphate (ATP)IBA 01/2006 - 12/2005
2	Membrane Transport Proteins (Biological Pump)IBA 12/2005 - 11/2003
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2022
1	remdesivirIBA 03/2021
1	DiglyceridesIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Insulin (Novolin)FDA Link 01/2017
1	Gentian Violet (Violet, Crystal)FDA Link 01/2015
1	Cytotoxins (Cytolysins)IBA 01/2015
1	Bendamustine Hydrochloride FDA Link 01/2015
1	EstersIBA 01/2015
1	Alkylating AgentsIBA 01/2015
1	Arginine (L-Arginine)FDA Link 12/2014
1	XenobioticsIBA 07/2013
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2013
1	Organic Cation Transporter 2IBA 07/2013
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 08/2012
1	AcidsIBA 08/2012
1	Mesalamine (Mesalazine)FDA LinkGeneric 06/2011
1	Therapeutic UsesIBA 06/2011
1	Antineoplastic Agents (Antineoplastics)IBA 03/2011
1	Estrogens (Estrogen)FDA Link 03/2011
1	Hormones (Hormone)IBA 03/2011
1	Latanoprost (Xalatan)FDA Link 05/2010
1	ProstaglandinsIBA 05/2010
1	DiureticsIBA 02/2010
1	Torsemide (Demadex)FDA LinkGeneric 02/2010
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2006
1	Phenobarbital (Luminal)FDA Link 12/2005
1	multidrug resistance-associated protein 1IBA 06/2005
1	radixinIBA 11/2003
1	Subfamily B ATP Binding Cassette TransporterIBA 11/2003
1	ParaffinIBA 04/2003
1	Carrier Proteins (Binding Protein)IBA 04/2003
1	Tumor Biomarkers (Tumor Markers)IBA 04/2003

Therapy/Procedure

1	Caloric Restriction 01/2017
1	Diet Therapy (Therapy, Diet) 08/2011
1	Transplantation 12/2010
1	Drug Therapy (Chemotherapy) 06/2005